Status:
WITHDRAWN
Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake
Lead Sponsor:
Charles Drew University of Medicine and Science
Conditions:
Covid19
Influenza
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This proposed study seeks to community knowledge and understand the experience of underserved communities in the exploration of reducing health disparities and increasing vaccine uptake and acceptabil...
Detailed Description
This study seeks to augment community knowledge and increase vaccine uptake among under-resourced African American and Latinx communities in South LA via leveraging trusted church leaders, educators a...
Eligibility Criteria
Inclusion
- Parishioner at a church receiving the VEPMP intervention
- Identify as African American or Latinx,
- at least 65 years and older
- Have Not received a vaccine for COVID-19, influenza, or pneumonia within the previous 24 months
- Agrees to study terms, which include follow-up interviews 9 and 18 months after study enrollment
Exclusion
- Does not attend or identify as a Parishioner at a church receiving the VEPMP intervention
- Does not identify as African American or Latinx
- Under the age of 65 years
- Received all vaccine doses for COVID-19, influenza, or pneumonia within the previous 24 months
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04761692
Start Date
October 1 2022
End Date
December 31 2026
Last Update
August 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles R. Drew University of Medicine & Science
Los Angeles, California, United States, 90059